MMAE (Monomethyl Auristatin E) is a powerful synthetic antineoplastic agent, originated from dolastatin 10, a compound extracted from the sea hare Dolabella auricularia. Known for its pronounced cytotoxicity, MMAE serves as a payload in antibody-drug conjugates (ADCs) aimed at targeted cancer treatment.
Besides MMAE, TBD offers an array of MMAE derivatives and linkers suitable for diverse ADC-related applications. Refer to the examples section for a list of production-ready solutions.
For further details or inquiries regarding other solutions, feel free to contact us directly.